Selenium and impaired physical function in US and Spanish older adults
E. García-Esquinas,
M. Carrasco-Rios,
R. Ortolá,
M. Sotos Prieto,
B. Pérez-Gómez,
E. Gutiérrez-González,
J.R. Banegas,
R. Queipo,
P. Olmedo,
F. Gil,
M. Tellez-Plaza,
A. Navas-Acien,
R. Pastor-Barriuso,
F. Rodríguez-Artalejo
Affiliations
E. García-Esquinas
Department of Preventive Medicine and Public Health. School of Medicine. Universidad Autónoma de Madrid, Madrid. Spain; IdiPaz (Instituto de Investigación Sanitaria Hospital Universitario La Paz), Madrid, Spain; CIBERESP (CIBER of Epidemiology and Public Health), Madrid, Spain; Corresponding author. Departamento Medicina Preventiva y Salud PúblicaUniversidad Autónoma de Madrid, Spain Calle del Arzobispo Morcillo 4, 28029, Madrid, Spain.
M. Carrasco-Rios
Department of Preventive Medicine and Public Health. School of Medicine. Universidad Autónoma de Madrid, Madrid. Spain
R. Ortolá
Department of Preventive Medicine and Public Health. School of Medicine. Universidad Autónoma de Madrid, Madrid. Spain; IdiPaz (Instituto de Investigación Sanitaria Hospital Universitario La Paz), Madrid, Spain; CIBERESP (CIBER of Epidemiology and Public Health), Madrid, Spain; Department of Environmental Health, Harvard T.H. Chan School of Public Health. Boston, MA, USA
M. Sotos Prieto
Department of Preventive Medicine and Public Health. School of Medicine. Universidad Autónoma de Madrid, Madrid. Spain; IdiPaz (Instituto de Investigación Sanitaria Hospital Universitario La Paz), Madrid, Spain; CIBERESP (CIBER of Epidemiology and Public Health), Madrid, Spain
B. Pérez-Gómez
CIBERESP (CIBER of Epidemiology and Public Health), Madrid, Spain; National Center of Epidemiology. Carlos III Health Institute, Madrid, Spain
E. Gutiérrez-González
Spanish Agency for Food Safety and Nutrition. Ministry of Health. Madrid, Spain
J.R. Banegas
Department of Preventive Medicine and Public Health. School of Medicine. Universidad Autónoma de Madrid, Madrid. Spain; IdiPaz (Instituto de Investigación Sanitaria Hospital Universitario La Paz), Madrid, Spain; CIBERESP (CIBER of Epidemiology and Public Health), Madrid, Spain
R. Queipo
IdiPaz (Instituto de Investigación Sanitaria Hospital Universitario La Paz), Madrid, Spain; Department of Medicine. School of Biomedical Sciences. Universidad Europea. Madrid, Spain
P. Olmedo
Department of Legal Medicine, Toxicology, and Physical Anthropology, School of Medicine, University of Granada, Granada, Spain
F. Gil
Department of Legal Medicine, Toxicology, and Physical Anthropology, School of Medicine, University of Granada, Granada, Spain
M. Tellez-Plaza
National Center of Epidemiology. Carlos III Health Institute, Madrid, Spain; Biomedical Research Institute Hospital Clinic de Valencia (INCLIVA), Valencia, Spain
A. Navas-Acien
Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, USA
R. Pastor-Barriuso
CIBERESP (CIBER of Epidemiology and Public Health), Madrid, Spain; National Center of Epidemiology. Carlos III Health Institute, Madrid, Spain
F. Rodríguez-Artalejo
Department of Preventive Medicine and Public Health. School of Medicine. Universidad Autónoma de Madrid, Madrid. Spain; IdiPaz (Instituto de Investigación Sanitaria Hospital Universitario La Paz), Madrid, Spain; CIBERESP (CIBER of Epidemiology and Public Health), Madrid, Spain; IMDEA Research Institute on Food and Health Sciences. Universidad Autónoma de Madrid + Centro Superior de Investigaciones Científicas (CSIC), Madrid, Spain
Background: Selenium (Se) is a trace element with a narrow safety margin. Objectives: To evaluate the cross-sectional and longitudinal dose-response association between Se exposure and measures of impaired physical function and disability in older adults. Design: NHANES 2011–2014 cross-sectional (US, n = 1733, age ≥60 years) and Seniors-ENRICA-2 2017–2019 cross-sectional and longitudinal (Spain, n = 2548 and 1741, respectively, age ≥65 years) data were analyzed. Whole blood and serum Se levels were measured using inductively coupled plasma-mass spectrometry. Lower-extremity performance was assessed with the Short Physical Performance Battery, and muscle weakness with a dynamometer. Incident mobility and agility limitations, and disability in instrumental activities of daily living (IADL) were ascertained with standardized questionnaires. Analyses were adjusted for relevant confounders, including physical activity. Results across studies were pooled using random-effects meta-analysis. Results: Meta-analyzed odds ratios (95% confidence interval) per log2 increase in whole blood Se were 0.54 (0.32; 0.76) for weakness, 0.59 (0.34; 0.83) for impaired lower-extremity performance, 0.48 (0.31; 0.68) for mobility limitations, 0.71 (0.45; 0.97) for agility limitations, and 0.34 (0.12; 0.56) for disability in at least one IADL. Analyses for serum Se in NHANES showed similar results. Findings suggest the inverse association with grip strength is progressive below 140 μg/L (p-value for non-linear trend in the Seniors-ENRICA-2 study = 0.13), and above 140 μg/L (p-value for non-linear trend in NHANES = 0.11). In the Seniors-ENRICA-2 cohort, with a 2.2 year follow-up period, a doubling in baseline Se levels were associated with a lower incidence of weakness [odds ratio (95% confidence interval): 0.45 (0.22; 0.91)], impaired lower-extremity performance [0.63 (0.32; 1.23)], mobility [0.43 (0.21; 0.91)] and agility [0.38 (0.18; 0.78)] limitations. Discussion: In US and Spanish older adults, Se concentrations were inversely associated with physical function limitations. Further studies are needed to elucidate underlying mechanisms.